Documentos relacionados

1. Changes in <i>Streptococcus pneumoniae</i> Susceptibility in Wisconsin: Implications for Clinical Treatment Decisions for Respiratory Infections.
2. Modelled Target Attainment after Temocillin Treatment in Severe Pneumonia: Systemic and Epithelial Lining Fluid Pharmacokinetics of Continuous versus Intermittent Infusions.
3. The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service.
4. Effectiveness of ampicillin and combination of penicillin and chloramphenicol in the treatment of pneumonias: randomized controlled trial.
5. [Treatment of acute pneumonia at different stages of the disease].
6. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial.
7. [Which antibiotics for pneumonia treatment?].
8. Management of Pediatric Pneumonia: A Decade After the Pediatric Infectious Diseases Society and Infectious Diseases Society of America Guideline.
9. Evolving antibiotic resistance in Group B Streptococci causing invasive infant disease: 1970-2021.
10. Antibiotics for bronchiolitis in children under two years of age.